ZYUS Life Sciences Corporation announced that Wayne Brownlee, who was conditionally appointed to the Company?s Board of Directors on June 28, 2023, has successfully obtained from Health Canada security clearance required to serve as a director of the Corporation pursuant to the Cannabis Act (Canada). With the appointment of Wayne Brownlee taking effect, the Company?s Board of Directors reconstituted its board committees as follows: Audit Committee: John Knowles (Chair), Garnette Weber and Wayne Brownlee. Compensation Committee: Garnette Weber (Chair), Richard Hoyt and Dr. Charlotte Moore Hepburn.

Governance and Nominating Committee: Richard Hoyt (Chair), John Knowles, Brent Zettl and Wayne Brownlee.